Sero-prevalence of SARS-CoV-2 antibodies in Ethiopia: Results of the National Population Based Survey, 2021

This study reveals the overall seroprevalence of SARS CoV-2 antibodies in Ethiopia was 10.0% as of May 2021. The seroprevalence of IgG antibodies against COVID-19 is higher than that of IgM antibodies, indicating a past infection. SARS-CoV-2 antibody seroprevalence was varied by regional state, sex, residence area, age, and occupational status. It also suggests that the majority of Ethiopia's have inadequate knowledge of understanding about SARS-CoV-2 antibodies, we recommend strengthening public health and social measures to mitigate the spread of COVID-19 diseases, including increased vaccination coverage and testing capability. All responsible authorities and stakeholders working locally, nationally, and globally need to support strengthening health systems and be prepared to combat morbidity and mortality and to encourage ongoing vaccination efforts. Periodic seroprevalence surveys will aid in monitoring the status and progress of the COVID-19 pandemic.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2025-05-06
DOI
https://doi.org/10.1371/journal.pone.0313791
Citations
1
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
1.40
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sero-prevalence of SARS-CoV-2 antibodies in Ethiopia: Results of the National Population Based Survey, 2021

Legesse Negash, Mohammad Ahmed, Desmond E. Williams, Laura Binkley et al.
1 citations
PLoS ONE
SARS-CoV-2 and COVID-19 Research
1.40
article

Sero-prevalence of SARS-CoV-2 antibodies in Ethiopia: Results of the National Population Based Survey, 2021

Legesse Negash, Mohammad Ahmed, Desmond E. Williams, Laura Binkley, Lia Tadesse Gebremedhin, Wondwossen A. Gebreyes, Jemal Ayalew, Abraham Ali, Birra Bejiga, Hiwot Moges, Joan-Miquel Balada-Llasat, Bernard Barekye, Getachew Tollera, Shuhua Wang, Geremew Tasew, Masresha Tessema, Fauziah Kassim, Mohd Gadaffie Abd Aziz, Getnet Yimer, Leuel Lisanwork, Marguerite Massinga Loembe, Eshetu Ejeta, Zelalem Mekuria, Dereje Duguma, Feyiso Bati, Saro Abdella, Dereje Nigussie, Adamu Tayachew, Enyew Birru
article en
1 citations

Abstract

This study reveals the overall seroprevalence of SARS CoV-2 antibodies in Ethiopia was 10.0% as of May 2021. The seroprevalence of IgG antibodies against COVID-19 is higher than that of IgM antibodies, indicating a past infection. SARS-CoV-2 antibody seroprevalence was varied by regional state, sex, residence area, age, and occupational status. It also suggests that the majority of Ethiopia's have inadequate knowledge of understanding about SARS-CoV-2 antibodies, we recommend strengthening public health and social measures to mitigate the spread of COVID-19 diseases, including increased vaccination coverage and testing capability. All responsible authorities and stakeholders working locally, nationally, and globally need to support strengthening health systems and be prepared to combat morbidity and mortality and to encourage ongoing vaccination efforts. Periodic seroprevalence surveys will aid in monitoring the status and progress of the COVID-19 pandemic.

PLoS ONEVol. 20(5)
Ohio Department of Health (US), Ethiopian Public Health Institute (ET), Federal Ministry of Health (ET), Africa Centres for Disease Control and Prevention (ET), Wollo University (ET), Ambo University (ET), International Trachoma Initiative (ET), The Ohio State University (US)
Good health and well-being
Openalex Percentile: Top 21%
SARS-CoV-2 and COVID-19 Research
1.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.